Bright Peak Therapeutics
Better Biologics Through Chemistry
56 employees · est. 2017 · Basel, Switzerland
Silverback Therapeutics is the older company (2017 vs 2016); Bright Peak Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Bright Peak Therapeutics | Silverback Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | Basel, Switzerland | Not tracked yet |
| Employees | ||
| Employees | 56 larger | 7 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Series C |
| Total Funding | ||
| Total Funding | $232.00M | $221.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Development of multifunctional precision immunotherapies through protein engineering and chemical synthesis | needle-free epinephrine nasal spray development, patient support and savings programs, pharmaceutical product innovation |
| Target Customers | ||
| Target Customers | Patients with cancer and autoimmune diseases, pharmaceutical companies, research institutions | patients requiring epinephrine, caregivers of patients, healthcare providers |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Biologics, Cytokines, Antibody Conjugation, Cancer Treatment, Autoimmune Disease Treatment, Therapeutic Antibodies, Drug Development, Innovation, Biotech Research, Cell-Specific Targeting, Efficacy Enhancement, Precision Medicine, ADC-like Conjugation Technology | Biopharmaceutical Company, Clinical-stage, ImmunoTAC Technology, Tissue Targeted Therapeutics, Cancer Treatment, Viral Infections Treatment, Immuno-oncology Agents, Myeloid Cell Activator, Solid Tumors, Antibody-guided Approach, Immuno-modulatory Pathways, Systemically Delivered Therapies, Disease-specific Targeting, R&D Approach, Potent Modulators |
| Website | ||
| Website | brightpeaktx.com | silverbacktx.com |
About Bright Peak Therapeutics
Bright Peak Therapeutics, founded in 2017 and headquartered in Switzerland, is revolutionizing biologics with its pioneering approach. The company's portfolio of first-in-class and best-in-class cytokines, aimed at treating cancer and autoimmune diseases, leverages proprietary technology platforms t...
About Silverback Therapeutics
Silverback Therapeutics is a clinical-stage biopharmaceutical company, established in 2016, centered around its proprietary ImmunoTAC technology platform. The company focuses on developing systemic, tissue-targeted therapeutics designed for treating cancer, chronic viral infections, and other seriou...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Bright Peak Therapeutics and Silverback Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Bright Peak Therapeuti... and Silverback Therapeutic... — by email.
Frequently Asked Questions
Compare Bright Peak Therapeutics with someone else
Start typing a company name or domain.